Appointment of Director

RNS Number : 2048B
Keystone Positive Change I.T. PLC
09 February 2022
 

Keystone Positive Change Investment Trust plc (KPC)

Appointment of Director

 

The Board of Keystone Positive Change Investment Trust plc ('the Company') is pleased to announce the appointment of Andrew Fleming as a non-executive Director of the Company with effect from 1 March 2022.

 

Mr Fleming began his career at Gartmore Investment Management, where he became deputy chief investment officer and head of equities. He went on to be global chief investment officer at ABN Amro Asset Management and was chief executive of Kames Capital for nine years. He was a non-executive director and chairman of JP Morgan Japanese Investment Trust plc until 2018, and a member of the Investment Committee of the National Trust until 2020. He is a trustee of the Rank Foundation, where he chairs its Investment Committee; a non-executive director of Polar Capital Global Healthcare Trust PLC; chairman of CTVC/Hillside Productions; and chairman of Saltus Asset Management. He has deep ESG experience having launched one of Europe's first environmental funds, been an early advocate of active equity voting and overseen Kames's award winning ethical investment capability.

 

Karen Brade, Chairman, commented "We are very pleased that Andrew has agreed to join the Board and look forward to benefiting from his wide-ranging insights on investing."

 

The appointment of Mr Fleming is subject to election by shareholders at the Annual General Meeting of the Company to be held in 2023.

 

Andrew Fleming currently holds no shares in the Company.

 

There is no further information required to be disclosed under Listing Rule 9.6.13.

 

 

Baillie Gifford & Co Limited

Managers and Secretaries

9 February 2022

 

 

 

 

 

Legal Entity Identifier: 5493002H3JXLXLIGC563

 

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFLEFFIAIIF
UK 100

Latest directors dealings